Schisandrin B exhibits anti-inflammatory activity through modulation of the redox-sensitive transcription factors Nrf2 and NF-κB

Free Radical Biology and Medicine

Volumn 53, Issue 7, 2012, Pages 1421-1430

  Checker, Rahul ^a   Patwardhan, Raghavendra S ^a   Sharma, Deepak ^a   Menon, Jisha ^a   Thoh, Maikho ^a   Bhilwade, Hari N ^a   Konishi, Tetsuya ^b   Sandur, Santosh K ^a  

^a BHABHA ATOMIC RESEARCH CENTRE   (India)

^b NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

Author keywords

Cytokines; Free radicals; Glutathione; Heme oxygenase 1; Lymphocytes; Reactive oxygen species

Indexed keywords

ANTIINFLAMMATORY AGENT; GLUTATHIONE; GLUTATHIONE DISULFIDE; HEME OXYGENASE 1; HEME OXYGENASE INHIBITOR; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGENIC AGENT; RAF PROTEIN; REACTIVE OXYGEN METABOLITE; SCHIZANDRIN B; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR NRF2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BASAL CELL; CELL NUCLEUS; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; GENE TRANSLOCATION; GENETIC TRANSCRIPTION; IN VIVO CULTURE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; T LYMPHOCYTE; UPREGULATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CONCANAVALIN A; CYCLOOCTANES; CYTOKINES; GENE EXPRESSION REGULATION; HEME OXYGENASE-1; I-KAPPA B KINASE; LIGNANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MALE; MEMBRANE PROTEINS; MICE; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NF-E2-RELATED FACTOR 2; NF-KAPPA B; OXIDATION-REDUCTION; POLYCYCLIC COMPOUNDS; PROTO-ONCOGENE PROTEINS P21(RAS); SIGNAL TRANSDUCTION; SPLEEN;

SCHISANDRA CHINENSIS;

EID: 84865739840     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2012.08.006     Document Type: Article

References (65)

1. P. Charles, M.J. Elliott, D. Davis, A. Potter, J.R. Kalden, C. Antoni, F.C. Breedveld, J.S. Smolen, G. Eberl, K. deWoody, M. Feldmann, and R.N. Maini Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis J. Immunol. 163 1999 1521 1528
2. M. Locati, and P.M. Murphy Chemokines and chemokine receptors: biology and clinical relevance in inflammation and AIDS Annu. Rev. Med 50 1999 425 440
3. K.J. O'Byrne, and A.G. Dalgleish Chronic immune activation and inflammation as the cause of malignancy Br. J. Cancer 85 2001 473 483
4. A.C. Allison Immunosuppressive drugs: the first 50 years and a glance forward Immunopharmacology 47 2000 63 83
5. P.F. Halloran Immunosuppressive drugs for kidney transplantation N. Engl. J. Med. 351 2004 2715 2729
6. G.T. Liu Pharmacological actions and clinical use of Fructus schizandrae Chin. Med. J. (Engl.) 102 1989 740 749
7. Ko, R., Mak, D.H.F. Schisandrin B and other dibenzocyclooctadiene ligands. Herbal and Traditional Medicine: Molecular Aspects of Health. In: P. Lester, C. Ong, and B. Halliwell, Eds. Marcel Dekker, New York, NY, USA, 2004: 289-314
8. T.M. Zhang, B.E. Wang, and G.T. Liu Effect of schisandrin B on lipoperoxidative damage to plasma membrane of rat liver in vitro Zhongguo Yao Li Xue Bao 13 1992 255 258
9. S.P. Ip, C.T. Che, Y.C. Kong, and K.M. Ko Effects of schisandrin B pretreatment on tumor necrosis factor-alpha induced apoptosis and Hsp70 expression in mouse liver Cell Stress Chaperones 6 2001 44 48
10. L. Li, Q. Lu, Y. Shen, and X. Hu Schisandrin B enhances doxorubicin-induced apoptosis of cancer cells but not normal cells Biochem. Pharmacol. 71 2006 584 595
11. P.Y. Chiu, D.H. Mak, M.K. Poon, and K.M. Ko Role of cytochrome P-450 in schisandrin B-induced antioxidant and heat shock responses in mouse liver Life Sci. 77 2005 2887 2895
12. S.P. Ip, and K.M. Ko The crucial antioxidant action of schisandrin B in protecting against carbon tetrachloride hepatotoxicity in mice: a comparative study with butylated hydroxytoluene Biochem. Pharmacol 52 1996 1687 1693
13. S.P. Ip, M.K. Poon, C.T. Che, K.H. Ng, Y.C. Kong, and K.M. Ko Schisandrin B protects against carbon tetrachloride toxicity by enhancing the mitochondrial glutathione redox status in mouse liver Free Radic. Biol. Med. 21 1996 709 712
14. S.P. Ip, H.Y. Yiu, and K.M. Ko Differential effect of schisandrin B and dimethyl diphenyl bicarboxylate (DDB) on hepatic mitochondrial glutathione redox status in carbon tetrachloride intoxicated mice Mol. Cell. Biochem 205 2000 111 114
15. S.P. Ip, H.Y. Yiu, and K.M. Ko Schisandrin B protects against menadione-induced hepatotoxicity by enhancing DT-diaphorase activity Mol. Cell. Biochem. 208 2000 151 155
16. 2-induced mitochondrial permeability transition and mitochondrial membrane potential in AML12 hepatocytes Phytother. Res 23 2009 1592 1602
17. L.E. Otterbein, F.H. Bach, J. Alam, M. Soares, Lu, H. Tao, M. Wysk, R.J. Davis, R.A. Flavell, and A.M. Choi Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway Nat. Med 6 2000 422 428
18. L.E. Otterbein, M.P. Soares, K. Yamashita, and F.H. Bach Heme oxygenase-1: unleashing the protective properties of heme Trends Immunol. 24 2003 449 455
19. D. Willis, A.R. Moore, R. Frederick, and D.A. Willoughby Heme oxygenase: a novel target for the modulation of the inflammatory response Nat. Med 2 1996 87 90
20. T.S. Lee, and L.Y. Chau Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice Nat. Med 8 2002 240 246
21. F.A. Wagener, H.D. Volk, D. Willis, N.G. Abraham, M.P. Soares, G.J. Adema, and C.G. Figdor Different faces of the heme-heme oxygenase system in inflammation Pharmacol. Rev. 55 2003 551 571
22. C. Dong, R.J. Davis, and R.A. Flavell MAP kinases in the immune response Annu. Rev. Immunol. 20 2002 55 72
23. Z. Sun, and R. Andersson NF-kappaB activation and inhibition: a review Shock 18 2002 99 106
24. E. Wegener, and D. Krappmann Dynamic protein complexes regulate NF-kappa B signaling Handb. Exp. Pharmacol 186 2008 237 259
25. P.A. Baeuerle The inducible transcription activator NF-kappa B: regulation by distinct protein subunits Biochim. Biophys. Acta 1072 1991 63 80
26. U. Siebenlist, G. Franzoso, and K. Brown Structure, regulation and function of NF-kappa B Annu. Rev. Cell Biol. 10 1994 405 455
27. R. Checker, D. Sharma, S.K. Sandur, G. Subrahmanyam, S. Krishnan, T.B. Poduval, and K.B. Sainis Plumbagin inhibits proliferative and inflammatory responses of T cells independent of ROS generation but by modulating intracellular thiols J. Cell. Biochem. 110 2010 1082 1093
28. I. Rahman, A. Kode, and S.K. Biswas Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method Nat. Protoc. 1 2006 3159 3165
29. M.W. Pfaffl, G.W. Horgan, and L. Dempfle Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR Nucleic Acids Res. 30 2002 e36
30. R. Checker, D. Sharma, S.K. Sandur, N.M. Khan, R.S. Patwardhan, V. Kohli, and K.B. Sainis Vitamin K3 suppressed inflammatory and immune responses in a redox-dependent manner Free Radic. Res. 45 2011 975 985
31. R. Checker, D. Sharma, S.K. Sandur, S. Khanam, and T.B. Poduval Anti-inflammatory effects of plumbagin are mediated by inhibition of NF-kappaB activation in lymphocytes Int. Immunopharmacol. 9 2009 949 958
32. R.S. Patwardhan, R. Checker, D. Sharma, V. Kohli, K.I. Priyadarsini, and S.K. Sandur Dimethoxycurcumin, a metabolically stable analogue of curcumin, exhibits anti-inflammatory activities in murine and human lymphocytes Biochem. Pharmacol. 82 2011 642 657
33. C. Wilankar, D. Sharma, R. Checker, N.M. Khan, R. Patwardhan, A. Patil, S.K. Sandur, and T.P. Devasagayam Role of immunoregulatory transcription factors in differential immunomodulatory effects of tocotrienols Free Radic. Biol. Med. 51 2011 129 143
34. Q. Ma, L. Battelli, and A.F. Hubbs Multiorgan autoimmune inflammation, enhanced lymphoproliferation, and impaired homeostasis of reactive oxygen species in mice lacking the antioxidant-activated transcription factor Nrf2 Am. J. Pathol. 168 2006 1960 1974
35. R.K. Thimmulappa, H. Lee, T. Rangasamy, S.P. Reddy, M. Yamamoto, T.W. Kensler, and S. Biswal Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis J. Clin. Invest. 116 2006 984 995
36. J.M. Lee, and J.A. Johnson An important role of Nrf2-ARE pathway in the cellular defense mechanism J. Biochem. Mol. Biol. 37 2004 139 143
37. B. Sun, X. Zou, Y. Chen, P. Zhang, and G. Shi Preconditioning of carbon monoxide releasing molecule-derived CO attenuates LPS-induced activation of HUVEC Int. J. Biol. Sci. 4 2008 270 278
38. Y. Liu, B. Zhu, X. Wang, L. Luo, P. Li, D.W. Paty, and M.S. Cynader Bilirubin as a potent antioxidant suppresses experimental autoimmune encephalomyelitis: implications for the role of oxidative stress in the development of multiple sclerosis J. Neuroimmunol. 139 2003 27 35
39. N.M. Khan, S.K. Sandur, R. Checker, D. Sharma, T.B. Poduval, and K.B. Sainis Pro-oxidants ameliorate radiation-induced apoptosis through activation of the calcium-ERK1/2-Nrf2 pathway Free Radic. Biol. Med. 51 2011 115 128
40. F. Tamion, V. Richard, S. Renet, and C. Thuillez Intestinal preconditioning prevents inflammatory response by modulating heme oxygenase-1 expression in endotoxic shock model Am. J. Physiol. Gastrointest. Liver Physiol. 293 2007 G1308 1314
41. K. Horvath, C. Varga, A. Berko, A. Posa, F. Laszlo, and B.J. Whittle The involvement of heme oxygenase-1 activity in the therapeutic actions of 5-aminosalicylic acid in rat colitis Eur. J. Pharmacol. 581 2008 315 323
42. P.J. Syapin Regulation of haeme oxygenase-1 for treatment of neuroinflammation and brain disorders Br. J. Pharmacol 155 2008 623 640
43. E. Heiss, C. Herhaus, K. Klimo, H. Bartsch, and C. Gerhauser Nuclear factor kappa B is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms J. Biol. Chem. 276 2001 32008 32015
44. S.K. Manna, A. Mukhopadhyay, and B.B. Aggarwal Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation J. Immunol 164 2000 6509 6519
45. A. Gopalakrishnan, and A.N. Tony Kong Anticarcinogenesis by dietary phytochemicals: cytoprotection by Nrf2 in normal cells and cytotoxicity by modulation of transcription factors NF-kappa B and AP-1 in abnormal cancer cells Food Chem. Toxicol 46 2008 1257 1270
46. M. Zhu, Y. Zhang, S. Cooper, E. Sikorski, J. Rohwer, and G.T. Bowden Phase II enzyme inducer, sulforaphane, inhibits UVB-induced AP-1 activation in human keratinocytes by a novel mechanism Mol. Carcinog. 41 2004 179 186
47. E.H. Kim, and Y.J. Surh 15-Deoxy-Delta12,14-prostaglandin J2 as a potential endogenous regulator of redox-sensitive transcription factors Biochem. Pharmacol. 72 2006 1516 1528
48. N. Chen, and M. Ko Schisandrin B-induced glutathione antioxidant response and cardioprotection are mediated by reactive oxidant species production in rat hearts Biol. Pharm. Bull 33 2010 825 829
49. P.K. Leong, P.Y. Chiu, N. Chen, H. Leung, and K.M. Ko Schisandrin B elicits a glutathione antioxidant response and protects against apoptosis via the redox-sensitive ERK/Nrf2 pathway in AML12 hepatocytes Free Radic. Res. 45 2011 483 495
50. J.E. Kim, D.J. You, C. Lee, C. Ahn, J.Y. Seong, and J.I. Hwang Suppression of NF-kappa B signaling by KEAP1 regulation of IKKbeta activity through autophagic degradation and inhibition of phosphorylation Cell. Signaling 22 2010 1645 1654
51. C. Xu, G. Shen, C. Chen, C. Gelinas, and A.N. Kong Suppression of NF-kappaB and NF-kappaB-regulated gene expression by sulforaphane and PEITC through IkappaBalpha, IKK pathway in human prostate cancer PC-3 cells Oncogene 24 2005 4486 4495
52. X.L. Chen, and C. Kunsch Induction of cytoprotective genes through Nrf2/antioxidant response element pathway: a new therapeutic approach for the treatment of inflammatory diseases Curr. Pharm. Des 10 2004 879 891
53. S.H. Lee, D.H. Sohn, X.Y. Jin, S.W. Kim, S.C. Choi, and G.S. Seo 2′,4′,6′-Tris(methoxymethoxy) chalcone protects against trinitrobenzene sulfonic acid-induced colitis and blocks tumor necrosis factor-alpha-induced intestinal epithelial inflammation via heme oxygenase 1-dependent and independent pathways Biochem. Pharmacol. 74 2007 870 880
54. S.M. Opal, and V.A. DePalo Anti-inflammatory cytokines Chest 117 2000 1162 1172
55. A.H. Sharpe, and G.J. Freeman The B7-CD28 superfamily Nat. Rev. Immunol. 2 2002 116 126
56. J. Reynolds, F.W. Tam, A. Chandraker, J. Smith, A.M. Karkar, J. Cross, R. Peach, M.H. Sayegh, and C.D. Pusey CD28-B7 blockade prevents the development of experimental autoimmune glomerulonephritis J. Clin. Invest. 105 2000 643 651
57. Y. Zhu, H. Ljunggren, E. Mix, H.L. Li, P. van der Meide, A.M. Elhassan, B. Winblad, and J. Zhu CD28-B7 costimulation: a critical role for initiation and development of experimental autoimmune neuritis in C57BL/6 mice J. Neuroimmunol. 114 2001 114 121
58. M. Lopez-Cabrera, A.G. Santis, E. Fernandez-Ruiz, R. Blacher, F. Esch, P. Sanchez-Mateos, and F. Sanchez-Madrid Molecular cloning, expression, and chromosomal localization of the human earliest lymphocyte activation antigen AIM/CD69, a new member of the C-type animal lectin superfamily of signal-transmitting receptors J. Exp. Med 178 1993 537 547
59. M. Salmon, P.A. Bacon, D.P. Symmons, and K.W. Walton Transferrin receptor expression by stimulated cells in mixed lymphocyte culture Immunology 54 1985 559 564
60. B.F. Haynes, M.E. Hemler, D.L. Mann, G.S. Eisenbarth, J. Shelhamer, H.S. Mostowski, C.A. Thomas, J.L. Strominger, and A.S. Fauci Characterization of a monoclonal antibody (4F2) that binds to human monocytes and to a subset of activated lymphocytes J. Immunol. 126 1981 1409 1414
61. H. Komada, A. Imai, E. Hattori, M. Ito, H. Tsumura, T. Onoda, M. Kuramochi, M. Tani, K. Yamamoto, M. Yamane, M. Kawano, M. Nishio, K. Yuasa, M. O'Brien, H. Yamamoto, J. Uematsu, M. Tsurudome, and Y. Ito Possible activation of murine T lymphocyte through CD98 is independent of interleukin 2/interleukin 2 receptor system Biomed. Res. 27 2006 61 67
62. Y. Zheng, S.L. Collins, M.A. Lutz, A.N. Allen, T.P. Kole, P.E. Zarek, and J.D. Powell A role for mammalian target of rapamycin in regulating T cell activation versus anergy J. Immunol. 178 2007 2163 2170
63. W. Zhao, W. Xie, Q. Xiao, D.R. Beers, and S.H. Appel Protective effects of an anti-inflammatory cytokine, interleukin-4, on motoneuron toxicity induced by activated microglia J. Neurochem. 99 2006 1176 1187
64. L.C. Ehrlich, S. Hu, W.S. Sheng, R.L. Sutton, G.L. Rockswold, P.K. Peterson, and C.C. Chao Cytokine regulation of human microglial cell IL-8 production J. Immunol. 160 1998 1944 1948
65. A. Ledeboer, J.J. Breve, S. Poole, F.J. Tilders, and A.M. Van Dam Interleukin-10, interleukin-4, and transforming growth factor-beta differentially regulate lipopolysaccharide-induced production of pro-inflammatory cytokines and nitric oxide in co-cultures of rat astroglial and microglial cells Glia 30 2000 134 142